NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biotech’

21 May 2015

Vivo Capital, Venrock help gene therapy business Regenxbio to weighty $70.5m Series D

microscope pic Gene therapy-focused biotech business Regenxbio has closed a hefty $70.5m Series D financing round thanks to investment from firms including Vivo Capital and Venrock.

19 May 2015

TPG Biotech hires ex-Novo Ventures partner Heath Lukatch

lab petri life science clinic US private equity giant TPG has hired experienced venture capital investor Heath Lukatch as a managing director and partner in its TPG Biotech platform.

7 May 2015

PE, VC Biotech investment jumped in April despite year-on-year slump $

biotech Strong US growth helped private equity and venture capital biotech investment numbers jump more than 80 per cent month-on month in April, new research shows.

13 April 2015

Biotech sees second month of declining investment from PE, VC firms $

venbio_sq.jpg Private equity and venture capital investment activity targeting the global biotechnology sector declined in March for the second month in a row, new research shows.

12 March 2015

Biotech PE, VC value up on 2015 despite monthly value drop $

lab petri life science clinic The value of private equity, venture capital and development capital investment targeting global biotechnology companies fell by 48 per cent in February compared to the previous month despite a year-on-year gain.

2 March 2015

VC-backed biotech business Canbex to be bought for €96m

lab petri life science clinic Venture capital-backed UK biotech business Canbex Therapeutics has agreed to be bought by Ipsen in a €96m deal.

10 February 2015

Weak start to the year for global biotech investment value $

biotech virus lab The value of private equity, venture capital and development capital investment in the global biotechnology sector decreased in January compared to the previous month despite a rise in volume. A total of $455m was invested in biotech companies over the four weeks, down 82 per cent from a high base of $2.58bn in December according to[...]

9 January 2015

Sofinnova Ventures hires biotech veteran Welch as executive partner

Dan W_1420698769 Life sciences investor Sofinnova Ventures has hired former biotech CEO Daniel Welch as executive partner.

6 January 2015

Pfizer leads $20m Series C round in CytomX to fight cancer

health Pfizer Venture Investments has led a $20m Series C financing round in biotech firm CytomX.

27 November 2014

Idinvest seals 7.6x return exiting Prosensa through $680m buyout

Prosensa Idinvest Partners has made a 7.6-times return by exiting its stake in Dutch biotechnology business Prosensa in a deal which values the business at $680m.

Page 1 of 1212345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015